Jazz Pharmaceuticals (JAZZ) Other Working Capital Changes (2011 - 2023)
Jazz Pharmaceuticals (JAZZ) posted quarterly Other Working Capital Changes of $529000.0 for Q3 2025, down 75.52% year-over-year from $2.2 million in Q3 2024, and down 33.21% quarter-over-quarter from $792000.0 in Q2 2025.
Powered by 
Analysis
Jazz Pharmaceuticals (JAZZ) Other Working Capital Changes (2011 - 2023) Analysis & Trends
Jazz Pharmaceuticals' Other Working Capital Changes history runs 15 years deep, the most recent figure standing at $529000.0 for Q3 2025.
- In Q3 2025, Other Working Capital Changes fell 75.52% year-over-year to $529000.0; the TTM figure through Sep 2025 stood at -$9.6 million (up 63.72% YoY), while the FY2024 annual figure was -$14.5 million, down 135.47% from the prior year.
- Other Working Capital Changes for Q3 2025 stood at $529000.0, down from $792000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $89.8 million in Q4 2023, with the low at -$54.9 million in Q1 2024.
- The 5-year median for Other Working Capital Changes is $516000.0 (2022), against an average of $1.9 million.
- The sharpest annual moves came in 2021 and 2022: Other Working Capital Changes plunged 1715.68% in 2021, then jumped 905.34% in 2022.
- Jazz Pharmaceuticals' Other Working Capital Changes stood at -$21.4 million in 2021, then soared by 54.14% to -$9.8 million in 2022, then tumbled by 171.43% to -$26.7 million in 2023, then surged by 44.32% to -$14.9 million in 2024, then soared by 103.56% to $529000.0 in 2025.
- Business Quant data shows JAZZ's Other Working Capital Changes at $529000.0 in Q3 2025, $792000.0 in Q2 2025, and $4.0 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Jazz Pharmaceuticals | 15.60 Bn | 13.98 Bn | 1.09 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -4,000.00 |
| Dec 31, 2023 | -4,000.00 |
| Mar 31, 2023 | -459,000.00 |
| Mar 31, 2023 | -459,000.00 |
| Dec 31, 2022 | -523,000.00 |
| Dec 31, 2022 | -523,000.00 |
| Sep 30, 2022 | -523,000.00 |
| Sep 30, 2022 | -523,000.00 |
| Jun 30, 2022 | -524,000.00 |
| Jun 30, 2022 | -524,000.00 |
| Mar 31, 2022 | -523,000.00 |
| Mar 31, 2022 | -523,000.00 |
| Dec 31, 2021 | -697,000.00 |
| Dec 31, 2021 | -697,000.00 |
| Sep 30, 2021 | -697,000.00 |
| Sep 30, 2021 | -697,000.00 |
| Jun 30, 2021 | -274,000.00 |
| Jun 30, 2021 | -274,000.00 |
| Mar 31, 2021 | -637,000.00 |
| Mar 31, 2021 | -637,000.00 |